4.6 Review

Breaking bad in the germinal center: how deregulation of BCL6 contributes to lymphomagenesis

Journal

TRENDS IN MOLECULAR MEDICINE
Volume 20, Issue 6, Pages 343-352

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.molmed.2014.03.001

Keywords

transcriptional repression; lymphomagenesis; gene enhancers; epigenetic regulation; BCL6; transcription factor targeted therapy

Funding

  1. NCI NIH HHS [R01 CA143032, R01 CA104348] Funding Source: Medline

Ask authors/readers for more resources

The B cell lymphoma 6 (BCL6) transcriptional repressor is a master regulator of the germinal center (GC) B cell program, required for their unique proliferative and stress tolerant phenotype. Most B cell lymphomas arise from GC B cells and are dependent on the continued or deregulated expression of BCL6 to maintain their survival. The actions of BCL6 in B cells involve formation of distinct chromatin modifying complexes that silence specific promoter and enhancer networks, respectively. The same biochemical mechanisms are maintained in malignant lymphoma cells. Targeted inhibition of these BCL6 functions has emerged as the basis for rational design of lymphoma therapies and combinatorial regimens. In this review, we summarize recent advances on BCL6 mechanisms of action and the deregulation of its target gene networks in lymphoma.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available